Xeloda capecitabine regulatory update

ROCZ submitted an sNDA for Xeloda, an oral prodrug form of 5-fluorouracil, as an adjuvant to treat colon cancer after surgery. ROCZ also submitted an application to EMEA for the same indication. The s...